Successful management of severe anemia without blood transfusion in pregnancy and puerperium using Mojeaga® as adjunct therapy: a report of two cases
Journal Title: Hong Kong Journal of Obstetrics and Gynaecology - Year 2018, Vol 1, Issue 1
Abstract
Background: Severe anemia occurring close to term pregnancy or puerperium usually requires blood transfusion for correction of anemia. We report two cases of Jehovah’s Witnesses (JW) patients with severe anemia who presented with management dilemma. The patients, along with their families and the Hospital Liaison Committee of JW vehemently refused blood or its products. Case summary: Case 1: A 25-year-old unbooked Nigerian woman, primigravida who presented at the gestational age of 37 weeks plus 3 days with severe anemia and intrauterine growth restriction. Anemia was corrected two weeks later with Mojeaga (a special blend of Alchornea, Pennisetum, and Sorghum extracts) 50 mls administered three times orally per day as an adjunct therapy to conventional oral iron therapy and she subsequently had elective induction of labor at the 40th week of gestation with spontaneous vertex delivery of a live male baby with birth weight of 2.3kg. Both mother and baby were discharged within 48 hours without any sequalae. Case 2: A 42-yearold multiparous Nigerian house wife with a history of progressive abdominal swelling noticed six weeks of her childbirth with associated weight loss. Her abdomen was distended and investigations revealed neutrophil leukocytosis, and severe anemia. Abdominal ultrasound revealed a large complex ovarian mass. Anemia was corrected two weeks later following intake of Mojeaga 50 mls administered three times orally per day as adjunct therapy to conventional oral iron therapy and she subsequently had ovariectomy. She made a complete recovery without blood transfusion. Conclusion: In these reports, we have described two cases of severe anemia in pregnancy and in puerperium who were successfully managed using Mojeaga as adjunct therapy to conventional oral iron therapy while maintaining patient autonomy. Future development of randomized trials is needed to prove efficacy and safety of Mojeaga as adjunct therapy to conventional oral iron therapy for correction of anemia in obstetrics and gynecology practice.
Authors and Affiliations
George Uchenna Eleje, Hillary Ikechukwu Obiagwu, Arnold Chidi Ogbuokiri, Chito Pachella Ilika, Emeka Pius Osuagwu
Keywords
Related Articles
- EP ID EP494840
- DOI -
- Views 49
- Downloads 0
Caesarean Section in Current Scenario: A Clinician’s Perspective
Tony Robbins would have not thought while quoting this line that at some point in time it would be very aptly applicable to all the obstetricians worldwide. Lower segment caesarean section (LSCS) is the most widely and m...
Emerging determinants of contraceptive practices among HIV-positive women on antiretroviral therapy in Nigeria
Objectives: To determine the prevalence of contraceptive use, preferences and determinants amongst HIV-positive women on anti-retroviral therapy. Methods: In this observational, analytical, cross-sectional study, partici...
Actuality of the diagnostic problem of purulentinflammatory diseases in modern medical practice
The problem of diagnostics is one of the main issues in medical practice. After all, the correct diagnosis allows us to choose the best effective therapeutic tactics. Therefore, the development of modern diagnostic metho...
Hepatitis B virus infection and infectivity status among pregnant women in Nigeria
Objectives: To determine the seroprevalence of hepatitis B surface antigen (HBsAg) and the infectivity status (HBeAg) among pregnant women. Methods: A cross sectional study carried out among pregnant women attending ante...
Successful management of severe anemia without blood transfusion in pregnancy and puerperium using Mojeaga® as adjunct therapy: a report of two cases
Background: Severe anemia occurring close to term pregnancy or puerperium usually requires blood transfusion for correction of anemia. We report two cases of Jehovah’s Witnesses (JW) patients with severe anemia who prese...